Trial Profile
Phase I pharmacokinetic trial of tetracosactide [RE 034]
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2021
Price :
$35
*
At a glance
- Drugs Tetracosactide (Primary)
- Indications Infantile spasms; Nephrotic syndrome
- Focus Pharmacokinetics
- 31 Dec 2013 New trial record